LEADER 01787nam  2200409 a 450 
001 9910699741303321
005 20101201095838.0
035   $a(CKB)5470000002405534
035   $a(OCoLC)688480887
035   $a(EXLCZ)995470000002405534
100   $a20101201d2010      ua             0
101 0 $aeng
135   $aurmn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aDirect-to-consumer genetic tests$b[electronic resource] $emisleading test results are further complicated by deceptive marketing and other questionable practices : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives /$fstatement of Gregory Kurtz
210  1$a[Washington, D.C.] :$cU.S. Govt. Accountability Office,$d[2010]
215   $a1 online resource (29 pages)
225 1 $aTestimony ;$vGAO-10-847T
300   $aTitle from PDF title screen (GAO, viewed Nov. 18, 2010).
300   $a"For release ... July 22, 2010."
320   $aIncludes bibliographical references.
517   $aDirect-to-consumer genetic tests 
606   $aDirect-to-consumer medical device advertising$zUnited States
606   $aHuman chromosome abnormalities$xDiagnosis
615  0$aDirect-to-consumer medical device advertising
615  0$aHuman chromosome abnormalities$xDiagnosis.
700   $aKutz$b Gregory D$01351611
712 02$aUnited States.$bCongress.$bHouse.$bCommittee on Energy and Commerce.$bSubcommittee on Oversight and Investigations.
712 02$aUnited States.$bGovernment Accountability Office.
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910699741303321
996   $aDirect-to-consumer genetic tests$93480974
997   $aUNINA